<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>TXA plasma concentration after different dosing strategies</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">TXA plasma concentration after different dosing strategies</h1>
<div class="graphic"><div class="figure"><div class="ttl">TXA plasma concentration after different dosing strategies</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Tranexamic acid (TXA) plasma concentration measured after administration of different dose schemes in adults and pediatrics.
<ul class="none">
<li><strong>High dose:</strong> 30 mg/kg loading dose, 2 mg/kg in cardiopulmonary bypass (CPB), and <span class="nowrap_whitespace">16 mg/kg<sup>–1</sup> h<sup>–1</sup>.</span></li>
<li><strong>Low dose:</strong> 10 mg/kg loading dose, 1 mg/kg in CPB, and <span class="nowrap_whitespace">1 mg/kg<sup>–1</sup> h<sup>–1</sup>.</span></li>
<li><strong>Continuous:</strong> 10 mg/kg loading dose, 10 mg/kg in CPB, and <span class="nowrap_whitespace">1 mg/kg<sup>–1</sup> h<sup>–1</sup>.</span></li>
<li><strong>Discontinuous:</strong> 10 mg/kg loading dose, 10 mg/kg in CPB, and 10 mg/kg at the end of CPB.</li>
</ul></div><div class="graphic_reference"><p>Reproduced with permission from: Koster A, Faraoni D, Levy JH. Antifibrinolytic therapy for cardiac surgery: An update. Anesthesiology 2015; 123(1):214-21. Copyright © 2015 American Society of Anesthesiologists, Inc. and Wolters Kluwer Health, Inc. <a href="https://pubs.asahq.org/anesthesiology" target="_blank">pubs.asahq.org/anesthesiology</a>.</p>
References:
<ol>
<li>Grassin-Delyle S, Couturier R, Abe E, et al. A practical tranexamic acid dosing scheme based on population pharmacokinetics in children undergoing cardiac surgery. Anesthesiology 2013; 118:853.</li>
<li>Bojko B, Vuckovic D, Mirnaghi F, et al. Therapeutic monitoring of tranexamic acid concentration: High-throughput analysis with solid-phase microextraction. Ther Drug Monit 2012; 34:31.</li>
<li>Grassin-Delyle S, Tremey B, Abe E, et al. Population pharmacokinetics of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass. Br J Anaesth 2013; 111:916.</li>
</ol></div><div id="graphicVersion">Graphic 142439 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
